Ledger.Open graph →
SEC Form D · Amendment · filed July 15, 2025

Sensorium Therapeutics, Inc

Offering
$58.5M
Sold
$26.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEDFORD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jerrold Rosenbaum · Waltham, MADirectorRyan Katz · Atlanta, GADirectorKevin Lalande · Austin, TXDirectorRichard Simon · New York, NYDirectorBalkrishan Gill · Wayne, PADirectorAlexandra Glucksmann · Cambridge, MADirectorJacob Hooker · Medford, MAExec · DirectorJerrold Rosenbaum · Waltham, MADirectorRyan Katz · Rockville, MDDirectorKevin Lalande · South San Francisco, CADirectorRichard Simon · Waltham, MADirectorBalkrishan Gill · Philadelphia, PADirectorAlexandra Glucksmann · Cambridge, MADirectorJacob Hooker · Medford, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗